Stabilizing (or even augmenting) the capacity of the LRP-1 transporters in the 'barriers' may be significant in slowing down the onset of NPH and/or the more severe stages of CSF-brain disruption in AD.
← all excerpts
Expression of the beta-amyloid transporter, LRP-1, in aging choroid plexus: implications for the CSF-brain system in NPH and Alzheimer's disease
1
—
—